Nonetheless, a recent Cochrane systematic review showed no difference with regards to live birth rates and incidence of OHSS in patients who received additional rLH to FSH compared to FSH monotherapy in COS [22]. Here, BRD2 is linked to ovarian hyperstimulation syndrome.